Related Experiment Video
Updated: Mar 7, 2026

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
Published on: May 27, 2022
Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis
Frederic Lamoth1,2,3,4, Shimin J Chung1,5, Lauro Damonti3
1Division of Infectious Diseases and International Health, Department of Medicine, and.
Abstract:
Breakthrough invasive mold infections (IMIs) that occur during posaconazole or voriconazole prophylaxis are rare complications for which epidemiological data are lacking. This retrospective analysis comparing 24 microbiologically documented breakthrough with 66 nonbreakthrough IMIs shows a shift towards non-Aspergillus molds with a significantly increased proportion of rare multidrug-resistant molds.
Insights
Breakthrough invasive mold infections during antifungal prophylaxis are rare but show a concerning rise in non-Aspergillus and multidrug-resistant molds, necessitating further study.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Invasive mold infections (IMIs) are serious complications in immunocompromised patients.
- Antifungal prophylaxis with posaconazole or voriconazole is standard, but breakthrough infections occur.
- Epidemiological data on breakthrough IMIs during prophylaxis are limited.
Purpose of the Study:
- To analyze the characteristics of breakthrough IMIs during posaconazole or voriconazole prophylaxis.
- To compare breakthrough IMIs with non-breakthrough IMIs in terms of causative agents.
- To identify trends in mold species and antifungal resistance.
Main Methods:
- Retrospective analysis of microbiologically documented IMIs.
- Comparison between breakthrough (n=24) and non-breakthrough (n=66) IMI cases.
- Identification of mold species and assessment of antifungal susceptibility.
Main Results:
- Breakthrough IMIs showed a shift towards non-Aspergillus molds.
- A significantly higher proportion of rare, multidrug-resistant molds were identified in breakthrough cases.
- Specific non-Aspergillus species and resistance patterns were noted.
Conclusions:
- Breakthrough IMIs during azole prophylaxis are associated with less common and more resistant mold pathogens.
- Current prophylaxis may be less effective against emerging resistant molds.
- Further research is needed to guide optimal antifungal strategies for these rare but severe infections.
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Fungal Phylum Ascomycota
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

